Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same author

AI-associated delusions: terminology.

The lancet. Psychiatry·2026
Same author

Minimally Invasive Versus Open Total Hysterectomy: From Practice Variability to a Decision Algorithm.

Life (Basel, Switzerland)·2026
Same author

Strategic Challenges of Hysterectomy in Benign Gynecological Pathology - Perspectives from a Systematic Review.

Chirurgia (Bucharest, Romania : 1990)·2026
Same author

NeuroMark-SZ: A Holistic Resting-State-fMRI-Based Model for Divergent Functional Circuitry in Schizophrenia.

bioRxiv : the preprint server for biology·2026
Same author

Recurrence patterns in primary urethral carcinoma: Prognostic impact of inguinal and pelvic lymphadenectomy.

Urologic oncology·2026

相关实验视频

Updated: Jul 5, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

如何将前列腺癌生物标志物纳入泌尿病学临床实践:最新情况

Catalin Baston1,2, Adrian Preda2, Alexandru Iordache2

  • 1Department of Nephrology, Urology, Immunology and Immunology of Transplant, Dermatology, Allergology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Cancers
|January 23, 2024
PubMed
概括

生物标志物通过改善诊断和治疗策略,有助于管理前列腺癌. 本综述强调了支持在局部和晚期前列腺癌临床决策中使用生物标志物的证据.

关键词:
生物标志物 生物标志物临床实践中的临床实践个性化医学是个性化的医学.个性化医疗是个性化的医疗.前列腺癌遗传学 前列腺癌遗传学

更多相关视频

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

230

相关实验视频

Last Updated: Jul 5, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

230

科学领域:

  • 尿瘤学 尿瘤学
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 前列腺癌的管理是复杂的,因为许多治疗方法和不断发展的理解.
  • 目前的风险分层系统缺乏个性化,影响临床决策和患者的结果.
  • 预后组内的疾病异质性挑战了有效的管理策略.

研究的目的:

  • 审查支持前列腺癌诊断和管理中生物标志物的临床实用性的科学证据.
  • 专注于泌尿学会推的生物标志物,并纳入泌尿瘤学指南.
  • 为解决局部和晚期前列腺癌的挑战性管理场景.

主要方法:

  • 关于前列腺癌生物标志物的科学证据的文献综述.
  • 在目前的泌尿瘤学指南中考虑的生物标志物的分析.
  • 专注于与诊断和复杂管理策略相关的生物标志物.

主要成果:

  • 几种生物标志物在帮助前列腺癌临床决策方面表现有前途.
  • 生物标志物证据支持将其纳入诊断过程.
  • 特定的生物标志物有助于指导局部和晚期疾病的管理.

结论:

  • 生物标志物是个性化前列腺癌管理的关键工具.
  • 有证据支持在临床实践中使用指南推的生物标志物.
  • 利用生物标志物可以优化治疗策略并改善瘤学结果.